Baxter International Inc (BAX) Actualités

Baxter Appoints Jeffrey A. Craig to Its Board

Addition of Mr. Craig complements current board expertise with deep financial, broad operational and public company board experience Baxter...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Spectral Medical Provides August Tigris Trial Update

TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a...

Baxter to Present at 2024 Wells Fargo Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September...

Form 8-K - Current report

Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion

Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Baxter Reports Second-Quarter 2024 Results

Second-quarter sales from continuing operations of $3.81 billion increased 3% on a reported basis and 4% on a constant currency basis, exceeding...

Form 8-K - Current report

Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results...

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend...

Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact

Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting...